Shouko Komori

Definitive Chemoradiation Therapy With Docetaxel, Cisplatin, and 5-Fluorouracil (DCF-R) in Advanced Esophageal Cancer: A Phase 2 Trial (KDOG 0501-P2)

Katsuhiko Higuchi, Shouko Komori, Satoshi Tanabe et al. · International Journal of Radiation Oncology*Biology*Physics · 2014 · 84 citations

Medicine, Oncology, Radiation Oncology +16

Radiotherapy for patients with unresectable advanced hepatocellular carcinoma with invasion to intrahepatic large vessels: Efficacy and outcomes

Yoshiaki Tanaka, Takahide Nakazawa, Shouko Komori et al. · Journal of Gastroenterology and Hepatology · 2013 · 37 citations

Medicine, Oncology, Radiation Oncology +16

Conversion surgery after combination chemotherapy of docetaxel, cisplatin and S-1 (DCS) for far-advanced gastric cancer

Hiroaki Mieno, Keishi Yamashita, Kei Hosoda et al. · Surgery Today · 2017 · 34 citations

Medicine, Oncology, Surgery +14

Clinical outcomes in patients with cancer of unknown primary site treated by gastrointestinal oncologists

Sakiko Yamane, Chikatoshi Katada, Satoshi Tanabe et al. · Journal of Translational Internal Medicine · 2017 · 31 citations · Full text

Medicine, Clinical Sciences, Oncology +8

Predisposing factors for chemotherapy-induced nephrotoxicity in patients with advanced esophageal cancer who received combination chemotherapy with docetaxel, cisplatin, and 5-fluorouracil

Junichi Mohri, Chikatoshi Katada, Marie Ueda et al. · Journal of Translational Internal Medicine · 2018 · 30 citations · Full text

Medicine, Oncology, Pharmacology +11